A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia AFlora Peyvandi, Frits R. Rosendaal, Pier Mannuccio Mannucci et al.|New England Journal of Medicine|2016Cited by 491
The use of a single von Willebrand factor‐containing, plasma‐derived FVIII product in hemophilia A immune tolerance induction: the US experienceMargaret Kurth, Louis M. Aledort, Charles L. Sexauer et al.|Journal of Thrombosis and Haemostasis|2011Cited by 46